UBS AM
ARAV

UBS AM’s Aravive, Inc. Common Stock ARAV Stock Holding History

UBS AM’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,083
Closed -$153K – 2698
2016
Q3 		$153K Hold
2,083
– – ﹤0.01% 2517
2016
Q2 		$138K Hold
2,083
– – ﹤0.01% 2542
2016
Q1 		$100K Hold
2,083
– – ﹤0.01% 2568
2015
Q4 		$155K Hold
2,083
– – ﹤0.01% 2598
2015
Q3 		$144K Hold
2,083
– – ﹤0.01% 2556
2015
Q2 		$190K Buy
+2,083
New +$211K ﹤0.01% 2597

Other funds holding ARAV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM's ARAV Position: Q4 2016 in Review

UBS AM sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2016, closing a stake of 2,083 shares — an estimated $153K sold.

UBS AM first reported a position in ARAV in Q2 2015 and held it in 6 quarters. The position peaked at $190K in Q2 2015. 75 funds tracked by Wall St. Rank hold ARAV as of Q4 2016.

  • UBS AM reported no remaining Aravive, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • UBS AM sold 2,083 Aravive, Inc. Common Stock shares in Q4 2016, an estimated $153K.
  • UBS AM first reported a position in Aravive, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
  • UBS AM's Aravive, Inc. Common Stock position peaked at $190K in Q2 2015.
  • 75 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2016.

Based on UBS AM's 13F filing for Q4 2016, filed 14 Feb 2017.